Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cost Quietly Remains The 800-Pound Gorilla In The CER Room

Executive Summary

In the run-up to passage of the Patient Protection and Affordable Care Act, there was much debate on the subject of cost effectiveness in the context of comparative effectiveness research, with legislators carefully wording CER provisions to keep cost effectiveness at bay

You may also be interested in...



Employers Eye CER To Improve Employee Health, Lower Costs – NPC Survey

Large employers and those companies that self-insure are expecting that comparative effectiveness research will lead to better employee health and help companies achieve their cost-management goals, according to the results of a survey released June 21 by the National Pharmaceutical Council.

Employers Eye CER To Improve Employee Health, Lower Costs – NPC Survey

Large employers and those companies that self-insure are expecting that comparative effectiveness research will lead to better employee health and help companies achieve their cost-management goals, according to the results of a survey released June 21 by the National Pharmaceutical Council.

CER Has Been A Part Of CMS Coverage Decisions In Recent Years – Avalere

During the health care reform debate, much concern was expressed that results of comparative effectiveness research from the Patient-Centered Outcomes Research Institute could play a key role in Medicare coverage decisions. But CER has already been considered in making Medicare coverage decisions for years, recent Avalere Health analysis of national coverage determinations issued by CMS points out.

Related Content

Topics

UsernamePublicRestriction

Register

PS052250

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel